It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

OptiBiotix Health plc (OPTI) Ord 2p

Sell:47.00p Buy:48.00p 0 Change: 1.50p (3.06%)
Market closed Prices as at close on 13 May 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:47.00p
Buy:48.00p
Change: 1.50p (3.06%)
Market closed Prices as at close on 13 May 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:47.00p
Buy:48.00p
Change: 1.50p (3.06%)
Market closed Prices as at close on 13 May 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company's principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is operated by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology. Its Optiscreen is a screening and optimization technology platform designed to identify microbes within the human microbiome with metabolic pathways, which can interact with human physiological processes. Its OptiBiotic is a platform technology, which generates compounds and screens them for their ability to modulate the human microbiome and its microbial end products. Its platforms are applicable across a range of other human diseases.

Contact details

Address:
Innovation Centre, Innovation Way
HESLINGTON
YO10 5DG
United Kingdom
Telephone:
+44 (020) 79338780
Website:
www.optibiotix.com/

Important dates

Future events
Final results 30 June 2021 30/06/21
Past events
Interim results 24 September 2020 24/09/20
Trading Announcement 20 July 2020 20/07/20
AGM 09 July 2020 09/07/20
Final results 28 May 2020 28/05/20
Trading Announcement 18 May 2020 18/05/20

General stock information

EPIC:
OPTI
ISIN:
GB00BP0RTP38
Market cap:
£41.77 million
Shares in issue:
87.94 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Stephen O'Hara
    Chief Executive Officer, Executive Director
  • Frederic Narbel
    Managing Director - Prebiotix, Executive Director
  • Sofia Kolyda
    Research and Development Director, Executive Director
  • Taru Jainas
    Business Development Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.